Lantern Pharma Announces Upcoming Conference Presentations
DALLAS, Aug. 27, 2020 /PRNewswire/ — Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (“A.I.”) platform to transform the pace, risk and cost of oncology drug discovery and development, and identify patients who…
Comments Off on Lantern Pharma Announces Upcoming Conference Presentations